Last reviewed · How we verify
NCT03891095
Oxytocin and Dopamine's Effect on Vicarious Optimism
NA trial testing Oxytocin in Oxytocin Group in 156 participants. Completed in 16 January 2019.
15 January 2019
Quick facts
| Lead sponsor | Beijing Normal University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 156 |
| Start date | 1 December 2018 |
| Primary completion | 15 January 2019 |
| Estimated completion | 16 January 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
Conditions studied
- Oxytocin Group — all drugs for Oxytocin Group →
- L-DOPA Group — all drugs for L-DOPA Group →
- Placebo Group — all drugs for Placebo Group →
Sponsor
Beijing Normal University
Who can join
Eligibility, male only, with Oxytocin Group or L-DOPA Group. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the effect of intranasal Oxytocin and L-DOPA's effect on vicarious optimism.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03891095
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Oxytocin
Trials testing the same drug.
- NCT07401524 — Carbetocin Uterotonic Treatment in Twin Pregnancies for Prevention of Postpartum Hemorrhage · Phase 4 · not yet recruiting
- NCT07188207 — Rectal Misoprostol for Reducing Blood Loss in Elective Cesarean Section · NA · not yet recruiting
- NCT06968481 — Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage · Phase 2 · not yet recruiting
- NCT07265180 — Oxytocin-Augmented Group Psychotherapy for Patients With Schizophrenia - an Oxytocin-dose Comparison · NA · recruiting
- NCT07119398 — Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM · Phase 4 · recruiting
Other Beijing Normal University trials
Trials by the same sponsor.
- NCT07379541 — Meditation-Based Online Psychological Intervention · NA · completed
- NCT06570083 — Mobile-Based Intervention to Promote Physical Activity Among the Elderly · NA · not yet recruiting
- NCT06570070 — AI-powered Chatbot vs. Human Counselors in Smoking Cessation · NA · not yet recruiting
- NCT06570122 — Mobile Phone-Based Smoking-Cessation Intervention for Smoking Parents · NA · not yet recruiting
- NCT06187142 — Mobile Phone-Based Smoking-Cessation Intervention for Chronic Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03891095 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Beijing Normal University
- Last refreshed: 26 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03891095.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing